Fresenius Medical Care AG & Co. KGaA (ETR:FME) received a €107.00 ($124.42) price target from equities researchers at HSBC in a note issued to investors on Tuesday. The brokerage presently has a “buy” rating on the stock. HSBC’s price objective indicates a potential upside of 21.04% from the stock’s current price.
FME has been the subject of several other reports. JPMorgan Chase & Co. set a €96.10 ($111.74) target price on Fresenius Medical Care AG & Co. KGaA and gave the company a “buy” rating in a research note on Thursday,....More>>>